Ali Amad Selected Research

Ali Amad Research Topics

Disease

6	Catatonia 03/2024 - 01/2016
6	Mental Disorders (Mental Disorder) 12/2023 - 01/2017
6	Hallucinations (Hallucination) 09/2023 - 03/2012
5	Bipolar Disorder (Manic Depressive Psychosis) 11/2020 - 01/2017
5	Schizophrenia (Dementia Praecox) 01/2019 - 08/2013
3	Psychotic Disorders (Schizoaffective Disorder) 09/2023 - 12/2014
3	Anxiety Disorders (Anxiety Disorder) 11/2020 - 01/2020
2	Medically Unexplained Symptoms 11/2023 - 01/2023
2	Alcoholism (Alcohol Abuse) 01/2021 - 01/2020
2	Mania (Manias) 01/2020 - 01/2017
2	Seizures (Absence Seizure) 05/2019 - 11/2018
2	Atherosclerosis 07/2015 - 08/2013
1	Dementia (Dementias) 03/2024
1	Substance-Related Disorders (Drug Abuse) 12/2023
1	Psychogenic Nonepileptic Seizures 01/2023
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2023
1	COVID-19 01/2023
1	Infections 01/2023
1	Mood Disorders (Mood Disorder) 01/2022
1	Depressive Disorder (Melancholia) 02/2020
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2020
1	Crohn Disease (Crohn's Disease) 01/2020
1	Rheumatoid Arthritis 01/2020
1	Conversion Disorder (Astasia Abasia) 05/2019
1	Psychomotor Agitation (Akathisia) 11/2018
1	Confusion (Bewilderment) 10/2018
1	Headache (Headaches) 10/2018
1	Memory Disorders (Memory Loss) 10/2018
1	Weight Loss (Weight Reduction) 01/2017
1	Erectile Dysfunction 01/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2015
1	Weight Gain 01/2015
1	Borderline Personality Disorder (Personality Disorders, Borderline) 01/2015
1	Fibromyalgia (Fibrositis) 05/2012

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 09/2023 - 07/2015
3	Advanced Glycation End ProductsIBA 01/2017 - 08/2013
2	Lorazepam (Ativan)FDA LinkGeneric 03/2024 - 11/2018
2	BenzodiazepinesIBA 02/2024 - 01/2022
2	Silver Sulfadiazine (SSD)FDA LinkGeneric 11/2023 - 01/2023
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2023 - 01/2014
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021 - 05/2012
2	ORALIT (ORS)IBA 11/2020 - 02/2020
2	3,4-methylenedioxyethamphetamine (MDEA)IBA 01/2020 - 12/2018
2	Glutamic Acid (Glutamate)FDA Link 01/2016 - 01/2014
2	Serotonin (5 Hydroxytryptamine)IBA 01/2014 - 05/2012
1	Amantadine (Aman)FDA LinkGeneric 03/2024
1	Polytetrafluoroethylene (Teflon)FDA Link 09/2023
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2023
1	C-Reactive ProteinIBA 01/2023
1	AntibodiesIBA 01/2023
1	IronIBA 01/2023
1	Antipsychotic Agents (Antipsychotics)IBA 01/2021
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2021
1	Opioid Analgesics (Opioids)IBA 01/2021
1	Antidepressive Agents (Antidepressants)IBA 01/2021
1	LithiumIBA 01/2021
1	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2021
1	Infliximab (Remicade)FDA Link 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	PlasticsIBA 01/2020
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2019
1	Vigabatrin FDA Link 11/2018
1	SolutionsIBA 01/2018
1	gamma-Aminobutyric Acid (GABA)IBA 01/2016
1	Aminobutyrates (Aminobutyric Acid)IBA 01/2016
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2015
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2015
1	Hallucinogens (Psychedelics)IBA 01/2014
1	Dissociative AnestheticsIBA 01/2014
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2014
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 05/2012
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 05/2012
1	Pregabalin (Lyrica)FDA Link 05/2012
1	Milnacipran (Ixel)FDA Link 05/2012

Therapy/Procedure

5	Transcranial Direct Current Stimulation 01/2023 - 01/2017
3	Therapeutics 01/2021 - 05/2012
2	Transcranial Magnetic Stimulation 01/2022 - 03/2012
1	Deinstitutionalization 12/2023
1	Institutionalization (Institutionalized Persons) 12/2023
1	Phototherapy (Light Therapy) 12/2018
1	Bathroom Equipment 11/2018
1	Anesthesia 10/2018
1	Bariatric Surgery 01/2017
1	Contraindications 12/2014